Mostrando 865–876 de 926 resultados

Vancomycin 125 mg, 14

218.97
La vancomicina es un antibiótico que pertenece a un grupo de antibióticos llamados "glucopéptidos".

Vancomycin 250 mg, 28

698.49
La vancomicina es un antibiótico que pertenece a un grupo de antibióticos llamados "glucopéptidos".

Vancomycin 250 mg, 30

821.83
La vancomicina es un antibiótico que pertenece a un grupo de antibióticos llamados "glucopéptidos".

Vancomycin 250 mg, 4

141.28
La vancomicina es un antibiótico que pertenece a un grupo de antibióticos llamados "glucopéptidos".

Vancomycin 500 mg, 1

45.58
La vancomicina es un antibiótico que pertenece a un grupo de antibióticos llamados "glucopéptidos".

Vancomycin 500 mg, 5

152.75
La vancomicina es un antibiótico que pertenece a un grupo de antibióticos llamados "glucopéptidos".

VANCOMYCIN ENTEROCAPS 250 mg Hartkapseln (Vancomycin hydrochloride),12 (FATOL Arzneimittel GmbH)

281.55
Vancomycin is used in adults and adolescents 12 years of age and older to treat mucosal infections of the small and large intestines (pseudomembranous colitis) caused by the bacterium Clostridium difficile.

VANCOMYCIN ENTEROCAPS 250 mg Hartkapseln (Vancomycin hydrochloride),12 (RIEMSER Pharma GmbH)

352.58
Vancomycin is used in adults and adolescents 12 years of age and older to treat mucosal infections of the small and large intestines (pseudomembranous colitis) caused by the bacterium Clostridium difficile.

VANCOMYCIN ENTEROCAPS 250 mg Hartkapseln (Vancomycin hydrochloride),28

628.13
Vancomycin is used in adults and adolescents 12 years of age and older to treat mucosal infections of the small and large intestines (pseudomembranous colitis) caused by the bacterium Clostridium difficile.

VAQTA 50 E/1 ml Injektionssuspension Fertigspr. (hepatitis A vaccine),1

81.41
Prevention of viral hepatitis A in adults and children from 12 months.

VAQTA 50 E/1ml (hepatitis A vaccine),1

81.41
Prevention of viral hepatitis A in adults and children from 12 months.

Varilrix (Varicella Zoster), 1 (EurimPharm Arzneimittel GmbH)

94.13
Planned prevention of chickenpox from 12 months, primarily in persons classified as high-risk groups who have not had chickenpox and have not been vaccinated previously.